Cas 1256485-41-2,2-morpholinoethyl 4-[(4-fluorophenyl)amino]-6-(methylcarbamoyl)-quinoiine-3-carboxylate

1256485-41-2

Post Buying Request

Basic information

Product Name: 2-morpholinoethyl 4-[(4-fluorophenyl)amino]-6-(methylcarbamoyl)-quinoiine-3-carboxylate
Synonyms: 2-morpholinoethyl 4-[(4-fluorophenyl)amino]-6-(methylcarbamoyl)-quinoiine-3-carboxylate
CAS NO:1256485-41-2
Molecular Formula:
Molecular Weight: 452.485
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-morpholinoethyl 4-[(4-fluorophenyl)amino]-6-(methylcarbamoyl)-quinoiine-3-carboxylate(CAS DataBase Reference)
NIST Chemistry Reference: 2-morpholinoethyl 4-[(4-fluorophenyl)amino]-6-(methylcarbamoyl)-quinoiine-3-carboxylate(1256485-41-2)
EPA Substance Registry System: 2-morpholinoethyl 4-[(4-fluorophenyl)amino]-6-(methylcarbamoyl)-quinoiine-3-carboxylate(1256485-41-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1256485-41-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1256485-41-2 Suppliers

Recommended suppliers

1256485-41-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1256485-41-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,6,4,8 and 5 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1256485-41:
(9*1)+(8*2)+(7*5)+(6*6)+(5*4)+(4*8)+(3*5)+(2*4)+(1*1)=172
172 % 10 = 2
So 1256485-41-2 is a valid CAS Registry Number.

1256485-41-2Upstream product

1256485-41-2Downstream Products

1256485-41-2Relevant academic research and scientific papers

SUBSTITUTED QUINOLINES FOR USE AS VEGF INHIBITORS

-

Page/Page column 46-47, (2010/12/18)

A compound of formula (I), as well as pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising a therapeutically effective amount of the compounds. The compound is useful in treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema and psoriasis.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1256485-41-2